Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: Implications for vaccine development

Vaccine

Volumn 21, Issue 21-22, 2003, Pages 2751-2757

  Maassen, Catharina B M ^a,b,d   Boersma, Wim J A ^c   Van Holten Neelen, Conny ^a   Claassen, Eric ^b   Laman, Jon D ^b  

^a TNO   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d Symbigene BV   (Netherlands)

Author keywords

Antibodies; Immunomodulators; Th1 Th2

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN SUBCLASS; PROBIOTIC AGENT;

ALLERGY; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPERIMENTAL TEST; FEMALE; GROWTH CURVE; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOTHERAPY; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS MURINES; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; STATISTICAL SIGNIFICANCE; TH2 CELL; VACCINE PRODUCTION; WILD TYPE;

EID: 0038513467     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00220-2     Document Type: Article

References (29)

1. Maassen C.B.M., Laman J.D., Heijne den Bak-Glashouwer M.J., Tielen F.J., van Holten-Neelen J.C.P.A., Hoogteijling L.et al. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine. 17(17):1999;2117-2128.
2. Seegers J.F. Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol. 20(12):2002;508-515.
3. Rosenfeldt V., Michaelsen K.F., Jakobsen M.et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr. Infect. Dis. J. 21(5):2002;411-416.
4. Shida K., Takahashi R., Iwadate E.et al. Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin. Exp. Allergy. 32(4):2002;563-570.
5. Shu Q., Gill H.S. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 34(1):2002;59-64.
6. Pessi T., Sutas Y., Hurme M., Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy. 30(12):2000;1804-1808.
7. Schultz M., Veltkamp C., Dieleman L.A.et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10 deficient mice. Inflamm. Bowel Dis. 8(2):2002;71-80.
8. Kato I., Endo K., Yokokura T. Effects of oral administration of Lactobacillus casei on anti-tumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 16(1):1994;29-36.
9. Maassen C.B.M., van Holten-Neelen J.C.P.A., Balk F., Heijne den Bak-Glashouwer M.J., Leer R.J., Laman J.D.et al. Strain dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine. 18:2000;2613-2623.
10. Kruisselbrink A., Heijne den Bak-Glashouwer M.J., Havenith C.E., Thole J.E., Janssen R. Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses. Clin. Exp. Immunol. 126(1):2001;2-8.
11. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85(1):2000;9-18.
12. Laman J.D., Thompson E.J., Kappos L. Balancing the Th1-Th2 concept in multiple sclerosis. Immunol. Today. 19(11):1998;489-490.
13. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8(3):1998;275-283.
14. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18(7):1997;335-343.
15. Kruger C., Hu Y., Pan Q.et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat. Biotechnol. 20(7):2002;702-706.
16. Shaw D.M., Gaerthe B., Leer R.J.et al. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunology. 100(4):2000;510-518.
17. Bokhout B.A., Van Gaalen C., Van der Heijden J. A selected water-in-oil emulsion: composition and usefulness as an immunological adjuvant. Vet. Immunol. Immunopathol. 2:1981;491.
18. Holzapfel W.H., Haberer P., Snel J., Schillinger U., Huis in't Veld J.H. Overview of gut flora and probiotics. Int. J. Food Microbiol. 41(2):1998;85-101.
19. Dunne C., O'Mahony L., Murphy L.et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am. J. Clin. Nutr. 73(Suppl. 2):2001;386S-392S.
20. Davies R.L. Outer membrane protein profiles of Yersinia ruckeri. Vet. Microbiol. 26(1-2):1991;125-140.
21. Derre I., Rapoport G., Msadek T. CtsR, a novel regulator of stress and heat shock response, controls clp and molecular chaperone gene expression in gram-positive bacteria. Mol. Microbiol. 31(1):1999;117-131.
22. Graumann P.L., Marahiel M.A. Cold shock proteins CspB and CspC are major stationary-phase-induced proteins in Bacillus subtilis. Arch. Microbiol. 171(2):1999;135-138.
23. Henderson B., Poole S., Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60(2):1996;316-341.
24. Hu Y., Coates A.R. Transcription of the stationary-phase associated hspX gene of mycobacterium tuberculosis is inversely related to synthesis of the 16-kD protein. J. Bacteriol. 181(5):1999;1380-1387.
25. Plant L.J., Conway P.L. Adjuvant properties and colonization potential of adhering and non-adhering Lactobacillus spp following oral administration to mice. FEMS Immunol. Med. Microbiol. 34(2):2002;105-111.
26. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal M.R.et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 283(5405):1999;1183-1186.
27. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168(1):2002;171-178.
28. Clements J.D. Surface warfare against pathogens using mucosal vaccines. Nat. Biotechnol. 15(7):1997;622-623.
29. Robinson K., Chamberlain L.M., Schofield K.M., Wells J.M., Le Page R.W. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15(7):1997;653-657.